Related Experiment Video
Updated: Jul 28, 2026

08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Aboulia: neurobehavioural dysfunction of dopaminergic system?
S Al-Adawi1, G S Dawe, A A Al-Hussaini
1Department of Behavioral Medicine & Psychiatry, College of Medicine, Sultan Qaboos University, Al-Khoudh, Muscat, Oman. Adawi@squ.edu.om
Medical Hypotheses
|June 22, 2000
Summary
Disorders marked by reduced thought and action, known as aboulia, may stem from failures in the brain
Area of Science:
- Neuroscience
- Psychiatry
- Neurology
Background:
- Advances in understanding goal-directed behavior highlight the need to investigate disorders with poverty of thought and action.
- Aboulia, characterized by apathy and lack of motivation, is a significant deficit in various neuropsychiatric conditions.
Purpose of the Study:
- To review evidence linking dopaminergic circuitry dysfunction to aboulia.
- To explore the implications of aboulia in neurological and psychiatric disorders.
- To examine preclinical and human studies on dopamine's role in aboulia.
Main Methods:
- Review of existing studies on dopamine agonism and antagonism.
- Analysis of human studies investigating dopamine's effects.
- Discussion of aboulia in clinical contexts, animal models, and pharmacological interventions.
Main Results:
- Converging evidence suggests that failure in the dopaminergic pathway (ventral tegmental area to nucleus accumbens to frontal cortex) can cause aboulia.
- Dopamine system dysfunction is implicated in the aboulia seen across diverse neurological and psychiatric conditions.
Conclusions:
- The dopaminergic system is critical for motivated behavior, and its failure leads to aboulia.
- Understanding the neural basis of aboulia is crucial for patient management, rehabilitation, and social integration.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

